5 terminated. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Terminated 5 |
| Phase 2 | 1 | Terminated 1 |
Follow Safety: new trials by email Literature Review of Safety trials Research Report on Safety
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single and Multiple Intravenous Administrations of Estetrol (E4) in Healthy Adult Volunteers single E4 28.3 mg, single E4 94.4 mg, multiple E4 94.4 mg - Safety, Pharmacokinetics | Phase 1 | Terminated | NEURALIS s.a. | 8 | 2022-04-19 | 2025-07-04 |
| Single and Multiple Dose Escalation Trial of an Intravenous Antibiotic RC-01 Single intravenous doses of RC-01, Single intravenous doses of placebo, Multiple intravenous doses of RC-01 - Safety | Phase 1 | Terminated | Recida Therapeutics, Inc. | 8 | 2019-04-14 | 2019-05-29 |
| TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms MDG1011, Investigator Choice therapy - Safety, Tolerability | Phase 1 / Phase 2 | Terminated | Medigene AG | 9 | 2018-03-27 | 2023-02-15 |
| First in Human Single Ascending Dose Study of MOR107 MOR107, Placebo, Low sodium diet - Safety | Phase 1 | Terminated | Alan Richardson | 24 | 2017-02-16 | 2018-02-07 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants MLN3126, MLN3126 Matched Placebo - Safety, Tolerability | Phase 1 | Terminated | Takeda | 23 | 2014-07-01 | 2016-07-25 |
Alan Richardson (1) · Medigene AG (1) · NEURALIS s.a. (1) · Recida Therapeutics, Inc. (1) · Takeda (1)
United States (2) · Bulgaria (1) · Germany (1) · United Kingdom (1)
Axel Mescheder, MD (1) · Simone Thomas, PD Dr. med. (1)